ALMKT:EPA
Mauna Kea Technologies SA
0,091 €
arrow_downward
−1,62%(−0,0015) 1 p
6. nov, 17:35:04 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
17,79Â mln
Keskm. maht
549,48Â tuh
Maht
385,57Â tuh
Hinna ja tulu suhe
0,78
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26Â mln
Töötajate arv
56
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
17,79Â mln
Keskm. maht
549,48Â tuh
Maht
385,57Â tuh
Hinna ja tulu suhe
0,78
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26Â mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo! Finance Canada
·
19 minuti eest
CABA,PFX,ELUT,HYPD,ZBIO,ALT,SELF,ENTX,SRBK,PCF,LUCK,GAIA,MDRR,CFBK,SPMC,GEF-B,MDBH,FRD,IRIX,RAL,RNXT,AIRJ | Stock Prices | Quote Comparison - Yahoo Finance
AP News
·
1 päeva eest
Carney welcomes Democrats’ push to end Trump’s tariffs on Canada after midterm victory
Bloomberg.com
·
1 päeva eest
Anatomy of a Selloff: Sudden Chain Reaction Rattles Wall Street
Investor's Business Daily
·
5 tunni eest
3 Titans Hold In Damaged Market; Berkshire Doubles Stock Buyback
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com